NasdaqGM:RXSTMedical Equipment
RxSight (RXST) Loss Widening To US$46.6 Million Tests Bullish Growth Narratives
RxSight (RXST) opened Q1 2026 with revenue of US$30.9 million, a basic EPS loss of US$0.38, and a net income loss of US$15.9 million, setting a cautious tone for the quarter at a share price of US$5.80. Over recent periods the company has seen quarterly revenue move from US$40.2 million in Q4 2024 to a range between US$30.3 million and US$37.9 million across 2025. Basic EPS has remained negative between US$0.15 and US$0.29 in those quarters, keeping profitability firmly in loss making...